These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 2371854)
1. The role of hypoglycemic sulphonylureas in arrhythmias contributing to the mortality in acute myocardial ischemia. Koltai MZ; Aranyi Z; Ballagi-Podány G; Pogátsa G Acta Physiol Hung; 1990; 75 Suppl():175-6. PubMed ID: 2371854 [No Abstract] [Full Text] [Related]
2. Effect of diabetes mellitus and its treatment on ventricular arrhythmias complicating acute myocardial infarction. Rana JS; Mukamal KJ; Nesto RW; Morgan JP; Muller JE; Mittleman MA Diabet Med; 2005 May; 22(5):576-82. PubMed ID: 15842512 [TBL] [Abstract][Full Text] [Related]
3. Possible risk of sulphonylureas in the treatment of non-insulin-dependent diabetes mellitus and coronary artery disease. Fasching P Diabetologia; 1998 Jun; 41(6):743-4. PubMed ID: 9662063 [No Abstract] [Full Text] [Related]
4. Cardiac complications in patients with diabetes mellitus. Shah S Angiology; 1978 Dec; 29(12):907-10. PubMed ID: 742730 [No Abstract] [Full Text] [Related]
5. [Effect of antidiabetic treatment in ischemic heart diseases]. Pogätsa G; Simon J; Koltai MZ; Ballagi-Pordány G; Aranyi Z Orv Hetil; 1990 Jan; 131(3):119-26. PubMed ID: 2405334 [TBL] [Abstract][Full Text] [Related]
6. Sulfonylureas and the risk of myocardial infarction. Thisted H; Johnsen SP; Rungby J Metabolism; 2006 May; 55(5 Suppl 1):S16-9. PubMed ID: 16631805 [TBL] [Abstract][Full Text] [Related]
8. A comment on 'the risk of coronary heart disease in type 2 diabetic patients exposed to thiazolidinediones compared to metformin and sulfonylurea therapy'. Chang Y; Choi NK; Hahn S; Park BJ Pharmacoepidemiol Drug Saf; 2007 Oct; 16(10):1072-3; author reply 1073-4. PubMed ID: 17907252 [No Abstract] [Full Text] [Related]
13. [Complications in the therapy of diabetes using oral hypoglycemic agents]. De Luca E; Pellegrini M Minerva Med; 1974 Dec; 65(90):4769-71. PubMed ID: 4449610 [No Abstract] [Full Text] [Related]
14. [Indications and limitations of oral hypoglycemic agents in the treatment of diabetes mellitus]. Guillon J; Charbonnel B Cah Med; 1972 Nov; 13(14):999-1006. PubMed ID: 4646244 [No Abstract] [Full Text] [Related]
15. The effect of various hypoglycaemic sulphonylureas on the cardiotoxicity of glycosides and arrhythmogenic activity due to myocardial ischaemia. Pogátsa G; Koltai MZ; Balkányi I; Dévai I; Kiss V; Köszeghy A Acta Physiol Hung; 1988; 71(2):243-50. PubMed ID: 3389169 [TBL] [Abstract][Full Text] [Related]
16. [Effect of sulfanilamide preparations on the blood coagulation system in patients with diabetes mellitus]. Vasiukova EA; Pisarskaia IV; Sharova IuA Ter Arkh; 1974; 46(10):53-5. PubMed ID: 4432223 [No Abstract] [Full Text] [Related]
18. [Influence of deficient kidney function on behavior of glipizide (hypoglycemic sulfonylurea) and its metabolites]. Fabre J; Balant L; Zahnd G J Urol Nephrol (Paris); 1973; 79(4):380-1. PubMed ID: 4720133 [No Abstract] [Full Text] [Related]
19. [Glipizide, a new sulfonylurea in the treatment of diabetes mellitus]. Villaseñor A Prensa Med Mex; 1973; 38(5):211-4. PubMed ID: 4782089 [No Abstract] [Full Text] [Related]
20. Sulphonylureas in the treatment of non-insulin-dependent diabetes. Ferner RE; Alberti KG Q J Med; 1989 Nov; 73(271):987-95. PubMed ID: 2695959 [No Abstract] [Full Text] [Related] [Next] [New Search]